Dr. Florence Bourgeois is Co-Director of the Harvard-MIT Center for Regulatory Science and Associate Professor of Pediatrics at Harvard Medical School. Her area of investigation focuses on applying clinical epidemiology and big data analytics to evaluate the regulation and use of medications in children and assess synthesis and integrity of clinical data to support evidence-based pediatric care. She is the Director of a Fellowship Program in Regulatory Science where she mentors students in interdisciplinary projects, including analysis of pharmaceutical development programs, prescription drug utilization, the impact of regulatory policies and incentive programs on drug and device development, and methodologies to augment postmarketing safety surveillance.
At Boston Children’s Hospital, Dr. Bourgeois is the Director of the Pediatric Therapeutics and Regulatory Science Initiative, which focuses on pediatric-specific drug policy and regulation and methods to advance evidence-based use of therapeutics in children. She has served as an Expert Visitor at the European Medicines Agency, where she led an evaluation of the implementation of the EUs Pediatric Regulation and its impact on increasing pediatric drug research and product labeling.
As faculty member in the Computational Health Informatics Program at Boston Children’s Hospital, Dr. Bourgeois is the Scientific Director of the Boston Children’s Hospital PrecisionLink Biobank. In this capacity, she collaborates on work developing novel approaches and informatics-based tools to integrate clinical data with biospecimens and to develop scalable infrastructures to expand capacity for biomedical research in pediatric patient populations, especially those with rare diseases. Her clinical training is in pediatrics and pediatric emergency medicine, and her research has been funded by the NIH, AHRQ, FDA, and the Burroughs Wellcome Fund.
Dr. Bourgeois is a graduate of Yale University and Washington University School of Medicine in St. Louis. She completed her residency training in pediatrics and fellowship in pediatric emergency medicine, both at Boston Children’s Hospital. She was a NRSA research fellow and obtained a Master in Public Health in clinical effectiveness at the Harvard School of Public Health.
Publications
Pediatric Exclusivity Revenues for Cancer Drugs. JAMA Pediatr. 2025 Jan 01; 179(1):91-93. View Abstract
The potential of Generative Pre-trained Transformer 4 (GPT-4) to analyse medical notes in three different languages: a retrospective model-evaluation study. Lancet Digit Health. 2025 Jan; 7(1):e35-e43. View Abstract
Publisher Correction: Conflict of interest disclosure in biomedical research: a review of current practices, biases, and the role of public registries in improving transparency. Res Integr Peer Rev. 2024 Dec 20; 9(1):13. View Abstract
US FDA Approval of Pediatric Artificial Intelligence and Machine Learning-Enabled Medical Devices. JAMA Pediatr. 2024 Dec 16. View Abstract
Mapping the Clinical Development Trajectory of Cell and Gene Therapy Products. Clin Pharmacol Ther. 2024 Dec 10. View Abstract
FDA Approval of Orphan Drug Indications for Pediatric Patients, 2011-2023. JAMA Pediatr. 2024 Dec 09. View Abstract
Naloxone Access Laws and Opioid-Related Overdose Deaths in Youths. JAMA Pediatr. 2024 Dec 01; 178(12):1368-1370. View Abstract
The Association of the Child Opportunity Index with Emergency Department Presentations for Pediatric Poisonings: A Case-Control Study. J Pediatr. 2024 Nov 15; 277:114410. View Abstract
The challenges of regulatory pluralism. Health Policy. 2024 Nov; 149:105164. View Abstract
Enrollment of underserved racial and ethnic populations in pediatric asthma clinical trials. J Allergy Clin Immunol Glob. 2024 Nov; 3(4):100315. View Abstract
Panel stacking is a threat to consensus statement validity. J Clin Epidemiol. 2024 Sep; 173:111428. View Abstract
Quantifying proportion of treatment effect by surrogate endpoint under heterogeneity. Stat Methods Med Res. 2024 Jul; 33(7):1152-1162. View Abstract
National Survey of FACT-Accredited Cell Processing Facilities: Assessing Preparedness for Local Manufacturing of Immune Effector Cells. Transplant Cell Ther. 2024 Jun; 30(6):626.e1-626.e11. View Abstract
Mental Health-Related Outpatient Visits Among Adolescents and Young Adults, 2006-2019. JAMA Netw Open. 2024 03 04; 7(3):e241468. View Abstract
Enrollment of Pediatric Patients in COVID-19 Interventional Trials. JAMA Health Forum. 2023 Nov 03; 4(11):e233939. View Abstract
National Patterns of Outpatient Follow-Up Visits After Emergency Care for Acute Bronchiolitis. JAMA Netw Open. 2023 10 02; 6(10):e2340082. View Abstract
Endovascular Aneurysm Repair Devices as a Use Case for Postmarketing Surveillance of Medical Devices. JAMA Intern Med. 2023 10 01; 183(10):1090-1097. View Abstract
A comparison of machine learning methods to find clinical trials for inclusion in new systematic reviews from their PROSPERO registrations prior to searching and screening. Res Synth Methods. 2024 Jan; 15(1):73-85. View Abstract
Clinical phenotypes and outcomes in children with multisystem inflammatory syndrome across SARS-CoV-2 variant eras: a multinational study from the 4CE consortium. EClinicalMedicine. 2023 Oct; 64:102212. View Abstract
Resource utilization among children presenting with cannabis poisonings in the emergency department. Am J Emerg Med. 2023 Nov; 73:171-175. View Abstract
Characteristics and Results of Pediatric Medical Device Studies: 2017-2022. Pediatrics. 2023 09 01; 152(3). View Abstract
Clinical development of new drugs for adults and children with cancer, 2010-2020. J Natl Cancer Inst. 2023 08 08; 115(8):917-925. View Abstract
Reporting and Representation of Participant Race and Ethnicity in National Institutes of Health-Funded Pediatric Clinical Trials. JAMA Netw Open. 2023 08 01; 6(8):e2331316. View Abstract
Data Sharing for Pediatric Clinical Trials Funded by the US National Institutes of Health. JAMA Netw Open. 2023 07 03; 6(7):e2325342. View Abstract
Clinical trials for paediatric cancers under new legislation in the USA. Lancet Child Adolesc Health. 2023 07; 7(7):e13. View Abstract
Advancing Equity in Medical Device Development for Children. JAMA Pediatr. 2023 06 01; 177(6):561-562. View Abstract
Association of prescription drug monitoring programs with benzodiazepine prescription dispensation and overdose in adolescents and young adults. Clin Toxicol (Phila). 2023 04; 61(4):234-240. View Abstract
Dissemination of the Results of Pediatric Clinical Trials Funded by the US National Institutes of Health. JAMA. 2023 02 21; 329(7):590-592. View Abstract
The state and future of pediatric research-an introductory overview : The state and future of pediatric research series. Pediatr Res. 2023 Jan 24. View Abstract
Association of Prescription Drug Monitoring Programs With Opioid Prescribing and Overdose in Adolescents and Young Adults. Ann Emerg Med. 2023 04; 81(4):429-437. View Abstract
High-risk Therapeutic Devices Approved by the US Food and Drug Administration for Use in Children and Adolescents From 2016 to 2021. JAMA Pediatr. 2023 01 01; 177(1):98-100. View Abstract
Systematic review of clinical drug development activities for neuroblastoma from 2011 to 2020. Pediatr Blood Cancer. 2023 05; 70(5):e30106. View Abstract
Hospitalizations Associated With Mental Health Conditions Among Adolescents in the US and France During the COVID-19 Pandemic. JAMA Netw Open. 2022 12 01; 5(12):e2246548. View Abstract
Trends in Dispensing of Controlled Medications for US Adolescents and Young Adults, 2008 to 2019. JAMA Pediatr. 2022 12 01; 176(12):1265-1266. View Abstract
Anatomical barriers against SARS-CoV-2 neuroinvasion at vulnerable interfaces visualized in deceased COVID-19 patients. Neuron. 2022 12 07; 110(23):3919-3935.e6. View Abstract
Regulatory considerations to keep pace with innovation in digital health products. NPJ Digit Med. 2022 Aug 19; 5(1):121. View Abstract
US Food and Drug Administration Approval of High-risk Cardiovascular Devices for Use in Children and Adolescents, 1977-2021. JAMA. 2022 08 09; 328(6):580-582. View Abstract
New legislation to promote paediatric studies for new cancer medicines. Lancet Oncol. 2022 08; 23(8):e368-e369. View Abstract
International electronic health record-derived post-acute sequelae profiles of COVID-19 patients. NPJ Digit Med. 2022 Jun 29; 5(1):81. View Abstract
Changes in laboratory value improvement and mortality rates over the course of the pandemic: an international retrospective cohort study of hospitalised patients infected with SARS-CoV-2. BMJ Open. 2022 06 23; 12(6):e057725. View Abstract
Association Between Molecular Streptococcal Testing and Antibiotic Use for Pharyngitis in Children. J Pediatric Infect Dis Soc. 2022 06 22; 11(6):303-304. View Abstract
International comparisons of laboratory values from the 4CE collaborative to predict COVID-19 mortality. NPJ Digit Med. 2022 Jun 13; 5(1):74. View Abstract
A Description of COVID-19-Directed Therapy in Children Admitted to US Intensive Care Units 2020. J Pediatric Infect Dis Soc. 2022 May 30; 11(5):191-198. View Abstract
Reporting of clinical trial safety results in ClinicalTrials.gov for FDA-approved drugs: A cross-sectional analysis. Clin Trials. 2022 08; 19(4):442-451. View Abstract
Data-Driven Approaches to Maximize the Impact of Pediatric Clinical Trials. Pediatrics. 2022 04 01; 149(4). View Abstract
Trends in Benzodiazepine Prescribing for US Adolescents and Young Adults From 2008 to 2019. JAMA Pediatr. 2022 03 01; 176(3):312-313. View Abstract
National Institutes of Health Funding Priorities-Reply. JAMA Pediatr. 2022 03 01; 176(3):325. View Abstract
Improving FDA postmarket adverse event reporting for medical devices. BMJ Evid Based Med. 2023 04; 28(2):83-84. View Abstract
Identifying unreported links between ClinicalTrials.gov trial registrations and their published results. Res Synth Methods. 2022 May; 13(3):342-352. View Abstract
National assessment of anti-epileptic drug exposures among pre-teens and adolescents, 2000-2020. Clin Toxicol (Phila). 2022 06; 60(6):681-687. View Abstract
Factors Associated With Corticosteroid Treatment for Pediatric Acute Respiratory Tract Infections. J Pediatric Infect Dis Soc. 2021 Dec 31; 10(12):1101-1104. View Abstract
The automation of relevant trial registration screening for systematic review updates: an evaluation study on a large dataset of ClinicalTrials.gov registrations. BMC Med Res Methodol. 2021 12 18; 21(1):281. View Abstract
Correlation Between National Institutes of Health Funding for Pediatric Research and Pediatric Disease Burden in the US. JAMA Pediatr. 2021 12 01; 175(12):1236-1243. View Abstract
Quantifying the feasibility of shortening clinical trial duration using surrogate markers. Stat Med. 2021 12 10; 40(28):6321-6343. View Abstract
Master Protocols and Adaptive Trial Designs to Develop Tumor-Agnostic Drugs for Children: Essential Tools in the Era of the Research to Accelerate Cures and Equity Act. JAMA Oncol. 2021 09 01; 7(9):1281-1282. View Abstract
Assessing the filtration efficiency and regulatory status of N95s and nontraditional filtering face-piece respirators available during the COVID-19 pandemic. BMC Infect Dis. 2021 Jul 29; 21(1):712. View Abstract
Trends in Gabapentin and Pregabalin Prescribing in a Tertiary Pediatric Medical Center. Hosp Pediatr. 2021 08; 11(8):909-914. View Abstract
National Trends in Disease Activity for COVID-19 Among Children in the US. Front Pediatr. 2021; 9:700656. View Abstract
Variation in Intravenous Acetaminophen Use in Pediatric Hospitals: Priorities for Standardization. Hosp Pediatr. 2021 07; 11(7):734-742. View Abstract
International Analysis of Electronic Health Records of Children and Youth Hospitalized With COVID-19 Infection in 6 Countries. JAMA Netw Open. 2021 06 01; 4(6):e2112596. View Abstract
Development and Validation of a Pediatric Comorbidity Index. Am J Epidemiol. 2021 05 04; 190(5):918-927. View Abstract
Evaluation of Publication of Pediatric Drug Trials. JAMA Netw Open. 2021 04 01; 4(4):e215829. View Abstract
International Comparisons of Harmonized Laboratory Value Trajectories to Predict Severe COVID-19: Leveraging the 4CE Collaborative Across 342 Hospitals and 6 Countries: A Retrospective Cohort Study. medRxiv. 2021 Feb 05. View Abstract
Analysis of SteraMist ionized hydrogen peroxide technology in the sterilization of N95 respirators and other PPE. Sci Rep. 2021 01 21; 11(1):2051. View Abstract
Association of Selective Serotonin Reuptake Inhibitors With the Risk of Type 2 Diabetes in Children and Adolescents. JAMA Psychiatry. 2021 01 01; 78(1):91-100. View Abstract
Antidiabetic medication use in commercially insured children and adolescents in the United States from 2004 to 2019. Diabetes Obes Metab. 2021 02; 23(2):444-454. View Abstract
The urgent need for research coordination to advance knowledge on COVID-19 in children. Pediatr Res. 2021 08; 90(2):250-252. View Abstract
Incompletely Reported Important Methodological Details and Inaccurate Description of the Formulation That the Control Arms Received in a Gardasil Vaccine Trial. mSphere. 2020 11 04; 5(6). View Abstract
Dynamic Dossier in the Cloud: A Sociotechnical Architecture for a Real-Time and Metrics-Based Data Tracking System with Gene and Cell Therapies as a Case Study. Ther Innov Regul Sci. 2021 03; 55(2):388-400. View Abstract
Pediatric Drug Policies Supporting Safe And Effective Use Of Therapeutics In Children: A Systematic Analysis. Health Aff (Millwood). 2020 10; 39(10):1799-1805. View Abstract
Association of State-Level Opioid-Reduction Policies With Pediatric Opioid Poisoning. JAMA Pediatr. 2020 10 01; 174(10):961-968. View Abstract
Landscape of phase 1 clinical trials for minors with cancer in the United States. Pediatr Blood Cancer. 2020 11; 67(11):e28694. View Abstract
Inclusion of Children in Clinical Trials of Treatments for Coronavirus Disease 2019 (COVID-19). JAMA Pediatr. 2020 Sep 01; 174(9):825-826. View Abstract
Assessing the quality of nontraditional N95 filtering face-piece respirators available during the COVID-19 pandemic. medRxiv. 2020 Jul 27. View Abstract
Personal Protective Equipment for COVID-19: Distributed Fabrication and Additive Manufacturing. Am J Public Health. 2020 08; 110(8):1162-1164. View Abstract
Is it time for computable evidence synthesis? J Am Med Inform Assoc. 2020 06 01; 27(6):972-975. View Abstract
Increasing Access to FDA Inspection Reports on Irregularities and Misconduct in Clinical Trials. JAMA. 2020 May 19; 323(19):1903-1904. View Abstract
Sponsorship of oncology clinical trials in the United States according to age of eligibility. Cancer Med. 2020 07; 9(13):4495-4500. View Abstract
Analysis of SteraMist ionized hydrogen peroxide technology in the sterilization of N95 respirators and other PPE: a quality improvement study. medRxiv. 2020 Apr 23. View Abstract
Adjuvant-containing control arms in pivotal quadrivalent human papillomavirus vaccine trials: restoration of previously unpublished methodology. BMJ Evid Based Med. 2020 Dec; 25(6):213-219. View Abstract
Improving Pediatric Academic Global Health Collaborative Research and Agenda Setting: A Mixed-Methods Study. Am J Trop Med Hyg. 2020 03; 102(3):649-657. View Abstract
Pediatric Trials for Cancer Therapies With Targets Potentially Relevant to Pediatric Cancers. J Natl Cancer Inst. 2020 03 01; 112(3):224-228. View Abstract
Off-label use of prescription analgesics among hospitalized children in the United States. Pharmacoepidemiol Drug Saf. 2020 04; 29(4):474-481. View Abstract
Correction: The Genomics Research and Innovation Network: creating an interoperable, federated, genomics learning system. Genet Med. 2020 Feb; 22(2):449. View Abstract
The use of opioids in low acuity pediatric trauma patients. PLoS One. 2019; 14(12):e0226433. View Abstract
Developing a pediatric pain data repository. JAMIA Open. 2020 Apr; 3(1):31-36. View Abstract
Noncompletion and nonpublication of trials studying rare diseases: A cross-sectional analysis. PLoS Med. 2019 11; 16(11):e1002966. View Abstract
Prescription opioid use and misuse among adolescents and young adults in the United States: A national survey study. PLoS Med. 2019 11; 16(11):e1002922. View Abstract
The Genomics Research and Innovation Network: creating an interoperable, federated, genomics learning system. Genet Med. 2020 02; 22(2):371-380. View Abstract
Promoting Pediatric Drug Research and Labeling - Outcomes of Legislation. N Engl J Med. 2019 08 29; 381(9):875-881. View Abstract
Importance of authorship and inappropriate authorship assignment in paediatric research in low- and middle-income countries. Trop Med Int Health. 2019 10; 24(10):1229-1242. View Abstract
Trends in Opioid Prescribing for Adolescents and Young Adults in Ambulatory Care Settings. Pediatrics. 2019 06; 143(6). View Abstract
Cost Implications of Escalating Intravenous Acetaminophen Use in Children. JAMA Pediatr. 2019 05 01; 173(5):489-491. View Abstract
Impact Of The Priority Review Voucher Program On Drug Development For Rare Pediatric Diseases. Health Aff (Millwood). 2019 02; 38(2):313-319. View Abstract
The timing and frequency of trial inclusion in systematic reviews of type 2 diabetes drugs was associated with trial characteristics. J Clin Epidemiol. 2019 05; 109:62-69. View Abstract
Neglected tropical diseases in children: An assessment of gaps in research prioritization. PLoS Negl Trop Dis. 2019 01; 13(1):e0007111. View Abstract
Trial2rev: Combining machine learning and crowd-sourcing to create a shared space for updating systematic reviews. JAMIA Open. 2019 Apr; 2(1):15-22. View Abstract
Completion Rate and Reporting of Mandatory Pediatric Postmarketing Studies Under the US Pediatric Research Equity Act. JAMA Pediatr. 2019 01 01; 173(1):68-74. View Abstract
Registration of published randomized trials: a systematic review and meta-analysis. BMC Med. 2018 10 16; 16(1):173. View Abstract
Availability of paediatric information in European Medicines Agency approvals. Lancet Child Adolesc Health. 2018 05; 2(5):e9. View Abstract
Delays in completion and results reporting of clinical trials under the Paediatric Regulation in the European Union: A cohort study. PLoS Med. 2018 03; 15(3):e1002520. View Abstract
A shared latent space matrix factorisation method for recommending new trial evidence for systematic review updates. J Biomed Inform. 2018 03; 79:32-40. View Abstract
Prevalence of Disclosed Conflicts of Interest in Biomedical Research and Associations With Journal Impact Factors and Altmetric Scores. JAMA. 2018 01 23; 319(4):408-409. View Abstract
Improving the Study of New Medicines for Children With Rare Diseases. JAMA Pediatr. 2018 Jan 01; 172(1):7-9. View Abstract
Unreported links between trial registrations and published articles were identified using document similarity measures in a cross-sectional analysis of ClinicalTrials.gov. J Clin Epidemiol. 2018 03; 95:94-101. View Abstract
Development of the Precision Link Biobank at Boston Children's Hospital: Challenges and Opportunities. J Pers Med. 2017 Dec 15; 7(4). View Abstract
Variation in Pediatric Procedural Sedations Across Children's Hospital Emergency Departments. Hosp Pediatr. 2018 01; 8(1):36-43. View Abstract
The Evolution of Patient Diagnosis: From Art to Digital Data-Driven Science. JAMA. 2017 Nov 21; 318(19):1859-1860. View Abstract
Pediatric drug information available at the time of new drug approvals: A cross-sectional analysis. Pharmacoepidemiol Drug Saf. 2018 02; 27(2):161-167. View Abstract
Variation in the evaluation of testicular conditions across United States pediatric emergency departments. Am J Emerg Med. 2018 Feb; 36(2):208-212. View Abstract
A systematic review of the processes used to link clinical trial registrations to their published results. Syst Rev. 2017 07 03; 6(1):123. View Abstract
Conclusions in systematic reviews of mammography for breast cancer screening and associations with review design and author characteristics. Syst Rev. 2017 05 22; 6(1):105. View Abstract
Complexity and Severity of Pediatric Patients Treated at United States Emergency Departments. J Pediatr. 2017 07; 186:145-149.e1. View Abstract
Exclusion of Elderly People from Randomized Clinical Trials of Drugs for Ischemic Heart Disease. J Am Geriatr Soc. 2017 Nov; 65(11):2354-2361. View Abstract
The Pediatric Research Equity Act Moves Into Adolescence. JAMA. 2017 01 17; 317(3):259-260. View Abstract
Discontinuation and Nonpublication of Randomized Clinical Trials Conducted in Children. Pediatrics. 2016 09; 138(3). View Abstract
Financial competing interests were associated with favorable conclusions and greater author productivity in nonsystematic reviews of neuraminidase inhibitors. J Clin Epidemiol. 2016 12; 80:43-49. View Abstract
Emergency Department Management of Febrile Respiratory Illness in Children. Pediatr Emerg Care. 2016 Jul; 32(7):429-34. View Abstract
Prevalence and Characteristics of Interventional Trials Conducted Exclusively in Elderly Persons: A Cross-Sectional Analysis of Registered Clinical Trials. PLoS One. 2016; 11(5):e0155948. View Abstract
Conflict of interest disclosure in biomedical research: A review of current practices, biases, and the role of public registries in improving transparency. Res Integr Peer Rev. 2016; 1. View Abstract
Drug-Drug Interactions Among Hospitalized Children Receiving Chronic Antiepileptic Drug Therapy. Hosp Pediatr. 2016 May; 6(5):282-9. View Abstract
Effect of Randomized Clinical Trial Findings on Emergency Management. Acad Emerg Med. 2016 Jan; 23(1):36-47. View Abstract
Measuring patient-perceived quality of care in US hospitals using Twitter. BMJ Qual Saf. 2016 06; 25(6):404-13. View Abstract
Comparison of Drug Utilization Patterns in Observational Data: Antiepileptic Drugs in Pediatric Patients. Paediatr Drugs. 2015 Oct; 17(5):401-10. View Abstract
Variation and Trends in Charges for Pediatric Care in Massachusetts Emergency Departments, 2000-2011. Acad Emerg Med. 2015 Oct; 22(10):1164-71. View Abstract
Industry-sponsored clinical research outside high-income countries: an empirical analysis of registered clinical trials from 2006 to 2013. Health Res Policy Syst. 2015 Jun 05; 13:28. View Abstract
Identifying Clinical Study Types from PubMed Metadata: The Active (Machine) Learning Approach. Stud Health Technol Inform. 2015; 216:867-71. View Abstract
Citations alone were enough to predict favorable conclusions in reviews of neuraminidase inhibitors. J Clin Epidemiol. 2015 Jan; 68(1):87-93. View Abstract
Financial conflicts of interest and conclusions about neuraminidase inhibitors for influenza: an analysis of systematic reviews. Ann Intern Med. 2014 Oct 07; 161(7):513-8. View Abstract
New regulatory paradigms for innovative drugs to treat pediatric diseases. JAMA Pediatr. 2014 Oct; 168(10):879-80. View Abstract
Variation in emergency department admission rates in US children's hospitals. Pediatrics. 2014 Sep; 134(3):539-45. View Abstract
Premarket safety and efficacy studies for ADHD medications in children. PLoS One. 2014; 9(7):e102249. View Abstract
Drug safety in the digital age. N Engl J Med. 2014 Jun 26; 370(26):2460-2. View Abstract
The effects of industry sponsorship on comparator selection in trial registrations for neuropsychiatric conditions in children. PLoS One. 2013; 8(12):e84951. View Abstract
Association between pediatric clinical trials and global burden of disease. Pediatrics. 2014 Jan; 133(1):78-87. View Abstract
Adult prescription drug use and pediatric medication exposures and poisonings. Pediatrics. 2013 Jul; 132(1):18-27. View Abstract
Use of QT-prolonging medications in US emergency departments, 1995-2009. Pharmacoepidemiol Drug Saf. 2014 Jan; 23(1):9-17. View Abstract
Analysis of pediatric clinical drug trials for neuropsychiatric conditions. Pediatrics. 2013 Jun; 131(6):1125-31. View Abstract
Industry influence in evidence production. J Epidemiol Community Health. 2013 Jul; 67(7):537-8. View Abstract
Pediatric versus adult drug trials for conditions with high pediatric disease burden. Pediatrics. 2012 Aug; 130(2):285-92. View Abstract
The role and impact of research agendas on the comparative-effectiveness research among antihyperlipidemics. Clin Pharmacol Ther. 2012 Apr; 91(4):685-91. View Abstract
Comparative effectiveness research: an empirical study of trials registered in ClinicalTrials.gov. PLoS One. 2012; 7(1):e28820. View Abstract
Factors associated with the use of cervical spine computed tomography imaging in pediatric trauma patients. Acad Emerg Med. 2011 Sep; 18(9):905-11. View Abstract
Adverse drug events in the outpatient setting: an 11-year national analysis. Pharmacoepidemiol Drug Saf. 2010 Sep; 19(9):901-10. View Abstract
Outcome reporting among drug trials registered in ClinicalTrials.gov. Ann Intern Med. 2010 Aug 03; 153(3):158-66. View Abstract
Neuroimaging for pediatric head trauma: do patient and hospital characteristics influence who gets imaged? Acad Emerg Med. 2010 Jul; 17(7):694-700. View Abstract
Relative impact of influenza and respiratory syncytial virus in young children. Pediatrics. 2009 Dec; 124(6):e1072-80. View Abstract
Pediatric adverse drug events in the outpatient setting: an 11-year national analysis. Pediatrics. 2009 Oct; 124(4):e744-50. View Abstract
"Left without being seen": a national profile of children who leave the emergency department before evaluation. Ann Emerg Med. 2008 Dec; 52(6):599-605. View Abstract
Evaluation of influenza prevention in the workplace using a personally controlled health record: randomized controlled trial. J Med Internet Res. 2008 Mar 14; 10(1):e5. View Abstract
The value of patient self-report for disease surveillance. J Am Med Inform Assoc. 2007 Nov-Dec; 14(6):765-71. View Abstract
Emergency care for children in pediatric and general emergency departments. Pediatr Emerg Care. 2007 Feb; 23(2):94-102. View Abstract
Influenza and other respiratory virus-related emergency department visits among young children. Pediatrics. 2006 Jul; 118(1):e1-8. View Abstract
Lumbar puncture ordering and results in the pediatric population: a promising data source for surveillance systems. Acad Emerg Med. 2006 Jul; 13(7):767-73. View Abstract
Validation of syndromic surveillance for respiratory infections. Ann Emerg Med. 2006 Mar; 47(3):265.e1. View Abstract
Association of race/ethnicity with emergency department wait times. Pediatrics. 2005 Mar; 115(3):e310-5. View Abstract